Skip to main content
. 2020 May 12;20:189. doi: 10.1186/s12886-020-01464-3

Table 3.

Treatment outcomes between Group A and Group B

Group A
(n = 22 eyes)
Group B
(n = 8 eyes)
P-value
Keratopathy 19 2 0.003a
Recurrence of the CNS lymphoma 6 3 0.666a
Follow-up time (month) 21 27 0.303b
Initial VA (LogMAR) 0.64 0.68 0.901b
Final VA (LogMAR) 0.32 0.18 0.517b

Group A = treated with induction-consolidation-maintenance regimen, Group B = treated with induction-maintenance regimen. a Fisher’s exact test, b t-test. VA visual acuity, CNS central nervous system